Correlation Between Mink Therapeutics and Avidity Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mink Therapeutics and Avidity Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mink Therapeutics and Avidity Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mink Therapeutics and Avidity Biosciences, you can compare the effects of market volatilities on Mink Therapeutics and Avidity Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mink Therapeutics with a short position of Avidity Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mink Therapeutics and Avidity Biosciences.

Diversification Opportunities for Mink Therapeutics and Avidity Biosciences

0.24
  Correlation Coefficient

Modest diversification

The 3 months correlation between Mink and Avidity is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Mink Therapeutics and Avidity Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avidity Biosciences and Mink Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mink Therapeutics are associated (or correlated) with Avidity Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avidity Biosciences has no effect on the direction of Mink Therapeutics i.e., Mink Therapeutics and Avidity Biosciences go up and down completely randomly.

Pair Corralation between Mink Therapeutics and Avidity Biosciences

Given the investment horizon of 90 days Mink Therapeutics is expected to generate 3.37 times more return on investment than Avidity Biosciences. However, Mink Therapeutics is 3.37 times more volatile than Avidity Biosciences. It trades about 0.1 of its potential returns per unit of risk. Avidity Biosciences is currently generating about 0.06 per unit of risk. If you would invest  630.00  in Mink Therapeutics on December 28, 2024 and sell it today you would earn a total of  220.00  from holding Mink Therapeutics or generate 34.92% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy98.36%
ValuesDaily Returns

Mink Therapeutics  vs.  Avidity Biosciences

 Performance 
       Timeline  
Mink Therapeutics 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Mink Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady forward-looking signals, Mink Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Avidity Biosciences 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Avidity Biosciences are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Avidity Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.

Mink Therapeutics and Avidity Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mink Therapeutics and Avidity Biosciences

The main advantage of trading using opposite Mink Therapeutics and Avidity Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mink Therapeutics position performs unexpectedly, Avidity Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avidity Biosciences will offset losses from the drop in Avidity Biosciences' long position.
The idea behind Mink Therapeutics and Avidity Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Fundamental Analysis
View fundamental data based on most recent published financial statements
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance